Target intelligence / Profile preview

Bacterial outer membrane phospholipids

Molecular classification
Lipid, Phospholipid
01

Overview

Bacterial outer membrane phospholipids are essential structural components of the Gram-negative bacterial cell envelope, primarily residing in the inner leaflet of the outer membrane. These lipids, which include phosphatidylethanolamine, phosphatidylglycerol, and cardiolipin, are vital for maintaining the membrane's structural integrity and its function as a selective permeability barrier (Sohlenkamp & Geiger, 2016). They provide a specialized environment for the assembly and activity of outer membrane proteins, which are crucial for nutrient uptake and waste export. In the context of infectious diseases, these phospholipids serve as a primary target for cationic antimicrobial peptides and polymyxin antibiotics (Poirel et al., 2017). These drugs interact electrostatically with the negatively charged phospholipid headgroups, leading to the displacement of stabilizing divalent cations and subsequent membrane disruption (Trimble et al., 2016). This disruption results in the leakage of cytoplasmic contents and cell death, making these lipids a critical focus for treating multi-drug resistant Gram-negative infections. However, the therapeutic use of agents targeting these lipids is often constrained by potential toxicity to host tissues, particularly the kidneys and nervous system.

Other names
Bacterial membrane lipidsGram-negative outer membrane phospholipidsAnionic bacterial phospholipidsPhosphatidylethanolamine (PE)Phosphatidylglycerol (PG)Cardiolipin (CL)
02

Mechanism of action

Binding to anionic phospholipids and lipopolysaccharides leads to the displacement of divalent cations (Ca2+ and Mg2+), resulting in the disruption of the outer membrane integrity, increased permeability, and eventual cell death.

03

Biological functions

Membrane integrityPermeability barrierCellular compartmentalizationProtein anchoringCell signaling
04

Disease associations

Bacterial infectionGram-negative bacterial infectionSepsis
05

Safety considerations

NephrotoxicityNeurotoxicityLow therapeutic indexPotential for cross-reactivity with host cell membranes
06

Interacting drugs

Polymyxin B

5 more in the full profile.

07

Biomarkers

Bacterial membrane potentialLipid A modification statusMinimum Inhibitory Concentration (MIC)Bacterial load

Beyond the preview

Go deeper on Bacterial outer membrane phospholipids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial outer membrane phospholipids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call